Break it Down: EBR completes first US commercial implants of WiSE CRT system

EBR Systems implants first two US commercial patients with WiSe CRT system for treating heart failure.

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

In this episode, host Tylah Tully looks at news from EBR Systems (ASX:EBR), who have implanted its first US commercial patients with the WiSE CRT System. 

The first US cases reflect two key uses for EBR’s technology. Treating patients previously untreatable due to a non-functional C-S lead and patients with pacing-induced heart failure following a Micra leadless pacemaker implant.

Watch the video to learn more.

While EBR Systems is a Stockhead advertiser, it did not sponsor this content.

Originally published as Break it Down: EBR completes first US commercial implants of WiSE CRT system